676 results found | searching for "pharma"

First Previous 1 2 3 4 5 6 7 8 9 10 Next Last 
  • vamshee
  • https://precisionbusinessinsights.com/market-reports/chromatography-resin-market/ Chromatography Resin Market: By Type (Natural, Synthetic, Inorganic Media), By Technique (Ion Exchange, Affinity, Size Exclusion, Hydrophobic Interaction)Application (Pharmaceutical and Biotechnology, Food and Beverage) By Geography
  • tansymolequle
  • PCD Pharma Franchise Company in Assam | Top PCD Pharma Franchise In Assam | Tansy Molequle Are You Looking To Join The Top Pharma Franchise Company In Assam To Gain Huge Profit? Get PCD Pharma franchise in Assam to get huge profit margin for Pharma franchise in Assam. Visit For More Information: https://www.tansymolequle.com/blog-detail/PCD-Pharma-Franchise-in-Assam
  • tansymolequle
  • PCD Pharma Franchise in Bihar | Tansy Molequle If You Want To Start A Profitable And Successful Pharma Franchise Business with the Leading PCD Pharma Franchise in Bihar Then Tansy Molequle Is The Most Famous and Greatest PCD Pharma Franchise in Bihar. Visit For More Information: https://www.tansymolequle.com/blog-detail/pcd-pharma-franchise-in-bihar
  • jameshebrew
  • The 4D bioprinting market is anticipated to grow at a CAGR of around 35% by 2035, claims Roots Analysis Owing to organ scarcity and lesser number of donors, the demand for tissue engineering and organ reconstruction has increased notably; as a result, the adoption of advanced 4D bioprinting technology is anticipated to increase over the coming years Roots Analysis has announced the addition of “4D Bioprinting Market, 2023-2035” report to its list of offerings. 4D bioprinting which involves the fourth spatio-temporal frame has diverse applications, including its use in drug regeneration and dynamic bio-constructs which can alter their shape with time. It has proven to be beneficial for research and development in the biopharmaceutical and healthcare industries. Presently, several players having dedicated facilities, cutting-edge machinery, and production lines, are engaged in the development of 4D bioprinters and smart biomaterials. In addition to the ability to morph, structures from 4D printing, have the ability to self-repair and can adapt to various environmental changes. Key Market Insights Currently, close to 60% of the 4D bioprinters are commercially available in the market Of these, over 45% of the 4D bioprinters are based on laser-based technology, followed by products based on polymer-based technology (20%). Further, about 60% of the 4D bioprinters use polymer as a biomaterial. Around 40% of the players developing smart biomaterials, are headquartered in Europe The market is currently dominated by the presence of large players (57%); of these, interestingly all the players have been established before 1980. Interestingly 68% of smart biomaterials developed in Europe are made up of polymers; of these close to 55% have already been commercialized. Publications related to the 4D bioprinting domain have been observed to grow at a CAGR of 130%, since 2016 Around 55% of the articles focused on 4D bioprinting were research articles, of these, more than 20% of the publications have been published in 2022. Further, popular journals that have published multiple articles include Polymers, Frontiers in Bioengineering and Biotechnology, and Micromachines Gels. Europe and Asia-Pacific are anticipated to capture a larger share (53%) of the market, by 2035 In addition, in terms of type of technology, the market is anticipated to be primarily driven by the laser-based technology capturing more than 35% of the market. Further, biomedical applications are expected to occupy a larger segment, sharing around 65% of the overall market, by 2035. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/4d-bioprinting-market/request-sample.html Key Questions Answered  What is meant by 4D Bioprinting?  How does 4D bioprinting work?  What are the benefits of 4D Bioprinting?  Who are the leading developers of 4D bioprinters and smart biomaterials?  Which is the hub of 4D bioprinter and smart biomaterial developers?  What is the relative competitiveness of different 4D bioprinter and smart biomaterial developers?  What is the relative competitiveness of different 4D bioprinters?  What are the strengths and threats for the developers engaged in the 4D bioprinting industry?  What is the focus of various publications related to 4D bioprinting?  What is the current / future market of 4D bioprinting? The financial opportunity within the 4D bioprinting market has been analyzed across the following segments:  Type of Technology  Extrusion-based Technology  Laser-based Technology  Inkjet-based Technology  Others  Application Area  Biomedical Applications  Others  End-user  Pharmaceutical and Biotechnology Companies  Academic Research and Development  Other end-users  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The opinions and insights presented in this report were also influenced by discussions held with eminent stakeholders in this industry. The report features detailed transcripts of interviews held with the following industry stakeholders:  Suhridh Sundaram (Chief Operating Officer, Avay Biosciences)  Preethem Srinath (Doctoral Candidate, CURAM)  Sam Onukuri (Independent Consultant) The research also includes profiles of key players (listed below) engaged in developing 4D bioprinters and smart biomaterials; each profile features an overview of the company, financial information (if available), details on product portfolio, recent developments, and an informed future outlook.  DirectSync Surgical  Enovis  Ferentis  Poietis  REGENHU  ROKIT Healthcare  Sculpteo  SMART3D  Stratasys  VIVAX BIO For additional details, please visit https://www.rootsanalysis.com/reports/4d-bioprinting-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035 2. AI-based Digital Pathology / AI Pathology Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 ben.johnson@rootsanalysis.com [more]
  • vamshee
  • https://precisionbusinessinsights.com/market-reports/potassium-carbonate-market/ Potassium Carbonate Market: By Product Type (Electrolysis Method, Ion Exchange Method, Ash Method and Other Methods), By Application (Pharmaceutical, Potassium Salts, Glass/TVs/Ceramic, Agrochemicals, Dyes & Inks, Rubber Chemicals and Others) and Geography
  • jameshebrew
  • The liposome development and manufacturing services market is anticipated to grow at a CAGR of nearly 10% till 2035, claims Roots Analysis Driven by the development of advanced methods for preparation and characterization of liposomes, and the application of these molecules in therapeutics and diagnostics, the demand for liposomes is expected to rise in the coming years. London Roots Analysis has announced the addition of “Liposome Manufacturing Market, 2022-2035” report to its list of offerings. Despite the growing interest in liposome-based therapeutics and diagnostics, the development and manufacturing of liposomes is associated with several challenges, including complex manufacturing processes, huge capital investments, inadequate clinical grade production and GMP compliant industrial scale-up, lack of facilities with necessary infrastructure, as well as concerns related to storage and stability. In order to deal with the aforementioned challenges, a number of pharmaceutical companies have demonstrated the preference to outsource their respective liposome development and manufacturing operations to specialized service providers. Key Market Insights More than 70 companies are currently offering services related to liposome development and manufacturing, globally Majority (74%) of the service providers offer formulation development services for liposomes. This is followed by players offering analytical method development (65%), liposome contract manufacturing (64%), and process development (61%) services. Close to 6,100 articles focused on liposomes, have been published in reputed scientific journals, since 2017 More than 50% of the articles focused on liposomes were published post-2019. Popular journals that have published multiple articles include International Journal of Pharmaceutics, Journal of Controlled Release, and Pharmaceutics. More than 800 clinical trials have been registered for the evaluation of liposome-based therapeutics, worldwide The clinical research activity, in terms of number of trials registered, is reported to have increased at a CAGR of 17%, during the period 2017-2021. Of the total number of trials registered, 60% have already been completed, while 26% of the studies are actively recruiting participants. Nearly 700 patents related to liposomes have been filed / granted, since 2017 Owing to the increase in research and development efforts led by several industry and non-industry players engaged in this domain, close to 55% of patent applications have been filed post-2016. It is worth noting that 61% patents related to liposomes were filed / granted in the US alone. Over 110 global events related to liposomes were organized in the past couple of years Majority (63%) of the events related to liposomes, were organized virtually in order to comply with the guidelines in the ongoing COVID-19 pandemic. Further, the agendas of the events organized post-2020 include discussions on the applications, and recent advancements in technologies associated with liposomes. Go / No-Go framework can be used to assist players in the crucial outsourcing decision-making process The framework enables evaluation of the current capabilities of liposome-based therapeutic developers, based on 4+ parameters, including trial phase, target therapeutic area, location of trial(s), patient enrollment and willingness to outsource. North America is anticipated to capture over 40% of the global market share for liposome development and manufacturing services, by 2035 In terms of type of product formulation, the therapeutic formulations of liposomes (71%) are anticipated to capture the highest share, this trend is unlikely to change in the foreseen future. Further, based on end users, majority of the revenue share (76%) of the overall market is likely to be driven by pharmaceutical and biotechnology industry, by 2035. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/liposome-manufacturing-market/request-sample.html Key Questions Answered  Who are the key players offering liposome development and manufacturing services?  What is the evolving trend of publications focused on liposomes?  How many patents, related to liposomes, have been filed / granted in the past few years?  Which companies are actively involved in conducting clinical trials for liposomes?  What are the key agenda items being discussed in various global events / conferences related to liposomes?  Which factors are likely to influence the decision of liposome manufacturing being done in-house or outsourced?  How is the current and future market opportunity related to liposome development and manufacturing services, likely to be distributed across key market segments? The financial opportunity within the liposome development and manufacturing services market has been analyzed across the following segments:  Type of Product Formulation  Therapeutic  Nutraceutical  Scale of Operation  Discovery / Research  Preclinical  Clinical  Commercial  End User  Pharmaceutical and Biotechnology Industry  Cosmetic Industry  Food Industry  Agricultural Industry  Academics  Other Industries  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The research also includes detailed profiles of the key players (listed below) offering services for liposome development and manufacturing; each profile features an overview of the company, its financial information (if available), details on service portfolio, recent developments and an informed future outlook.  Baxter BioPharma Solutions  Charles River Laboratories  Evonik  Fresenius Kabi  Fujifilm  GEA  Intertek For additional details, please visit https://www.rootsanalysis.com/reports/liposome-manufacturing-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Biologics Fill Finish Services Market (3rd Edition), 2022-2035 2. Bioavailability Enhancement Technologies and Services Market, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com [more]
  • rekha
  • https://precisionbusinessinsights.com/market-reports/asia-pacific-influenza-treatment-market/ The asia pacific influenza treatment market size was valued at USD 2,963.1 million in 2021, growing at a CAGR of 7.1% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Asia Pacific Influenza Treatment Market By Drug Class (Anti-Viral Drugs, Interferons, Vaccines), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others).– Global/Region/Country Forecast to 2028”. [more]
  • Healthcare_medical
  • Biological Safety Cabinet Market worth $0.4 billion by 2027 https://bit.ly/3CA0TZn The global biological safety cabinet market is projected to reach USD 0.4 billion by 2027 from USD 0.2 billion in 2022, at a CAGR of 8.2% during the forecast period. Growth in the biological safety cabinet market is mainly driven by factors such as the increase in favorable regulations in pharmaceutical and biopharmaceutical companies and increase in number of communicable diseases. The major players in this market are Thermo Fisher Scientific (US), Kewaunee Scientific (US), Labconco (US), Esco Micro (Singapore), The Baker Company (US), NuAire (US), Germfree Laboratories (US), Cruma (Spain), Air Science (US), Berner International (US), Azbil telstar (Spain), LaboGene (Denmark), Biolab Scientific (Canada), Lamsystems (Germany), Faster S.R.L (Italy), MRC Laboratory Equipment (Israel), Nanbei Instrument Limited (China), Thermolab (India), Labmate (UK), TopAir Systems, Inc. (US), Albian Group (Spain), Thomas Scientific (US), Zhejiang FUXIA Medical Technology Co. (China), Stericox (India) [more]
  • jameshebrew
  • The dental 3D printing market is anticipated to grow at a CAGR of 15.1% during the period 2023-2035, claims Roots Analysis The growing burden of dental diseases and the challenges associated with the conventional dental product manufacturing methods has significantly increased the adoption of 3D printing in the dental industry Roots Analysis has announced the addition of “Dental 3D Printing Market, 2023 – 2035” report to its list of offerings. The popularity of 3D printing technology within the dental industry can be attributed to its ability to print high quality / accurate dental products, including crowns, bridges, dentures, dental implants and surgical guides. Driven by the overall growth of the additive manufacturing (3D printing) industry, and wide adoption of 3D printers in the dental sector, the dental 3D printing market is anticipated to witness a steady growth in the foreseen future. Key Market Insights Currently, around 230 dental 3D printers are available for use across wide range of applications Majority (38%) of the dental 3D printers use digital light processing (DLP) as printing technology, followed by those using stereolithography (SLA) technology (21%). Further, close to 75% of the dental 3D printers can produce crowns / bridges / dentures, followed by those manufacturing working models (61%) and surgical guides (59%). It is worth highlighting that around 55% of the dental 3D printers currently available in the market have a price range below USD 10,000. More than 80 companies claim to offer dental 3D printers, across the world Majority of the firms (46%) engaged in this domain are mid-sized players, followed by large (32%) and small firms (22%). It is worth highlighting that, more than 50% of the companies in this domain have been established post-2010. Further, around 85% of the dental 3D printer manufacturers are based in Asia-Pacific and Europe, followed by those headquartered in North America (16%), and within the Asia-Pacific region, China emerged as the most prominent hub, featuring the presence of maximum number of players (62%). Partnership activity has grown at an annualized rate of over 70%, between 2018-2022 Maximum number of partnerships were established in 2021 (56) and 2022 (44), indicating the recent surge in the partnership activity in this domain. Majority of these (26%) were product integration agreements. Further, most of the intercontinental as well as intracontinental deals have been inked by the players based in North America. 500+ patents related to dental 3D printing have been granted / filed between 2019 and 2022 R&D activity related to dental 3D printing is largely concentrated in Asia-Pacific, considering the fact that 50% of the total number of patents were filed in this region. It is worth highlighting that, within the Asia-Pacific region, China emerged as the most active country with ~230 filed patents. In addition, most of the patents in this domain are patent applications (65%). North America and Europe are anticipated to capture around 75% share of the market by 2035 In addition, the market in Asia-Pacific is likely to grow at a relatively faster pace (with CAGR of 16.3%) in the long term. Further, in 2035, based on type of printing technology, majority of the revenue share (64%) of the overall market is likely to be driven by vat polymerization technology. Further, in terms of application area, prosthodontics currently holds largest share (55%) of the market. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/dental-3d-printing-market/request-sample.html Key Questions Answered  How is 3D printing used in the dental industry?  How many dental 3D printers are currently available in the market?  Which 3D printers are best for dentistry?  What is the growth rate of the dental 3D printing market?  Which region captures the largest share of the dental 3D printing market?  Which printing technology is widely used in the dental 3D printers?  Which application area currently holds the largest share in the dental 3D printing market?  What are the partnerships and collaborations trend in the dental 3D printing domain?  How many patents have been filed / granted related to dental 3D printing in the recent years? The financial opportunity within the dental 3D printing market has been analyzed across the following segments:  Type of Printing Technology  VAT Polymerization Technology  Powder Bed Fusion Technology  Polyjet Technology  Metal Extrusion Technology  Other Technologies  Application Area  Prosthodontics  Orthodontics  Dental Implants  Other Applications  Type of Printing Material  Resins  Plastics  Metals  Metals  Other Material  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World The research also includes detailed profiles of key players (listed below) featuring a brief overview of the company, details related to dental 3D printer portfolio, recent developments, and an informed future outlook.  3D Systems  Asiga  BEGO  Carbon  Digital Wax Systems (DWS)  Formlabs  Prodways  Rapid Shape  SprintRay  Stratasys For additional details, please visit https://www.rootsanalysis.com/reports/dental-3d-printing-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035 2. Medical Devices Contract Research Organizations Market (3rd Edition): Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com [more]
  • yamunapharmacy
  • Best Unani Medicine Manufacturer in India - Yamuna Pharmacy Are you looking for the best GMP-certified ayurvedic and herbal medicine manufacturer in India? Yamuna pharmacy is here for you! Get quality and effective products online for better results without any side effects. Purchase herbal products directly from manufacturers without any mediator online. Visit https://yamunapharmacy.com now! [more]
First Previous 1 2 3 4 5 6 7 8 9 10 Next Last